pubmed-article:17483529 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17483529 | lifeskim:mentions | umls-concept:C0600097 | lld:lifeskim |
pubmed-article:17483529 | lifeskim:mentions | umls-concept:C0021102 | lld:lifeskim |
pubmed-article:17483529 | lifeskim:mentions | umls-concept:C0547040 | lld:lifeskim |
pubmed-article:17483529 | lifeskim:mentions | umls-concept:C1704229 | lld:lifeskim |
pubmed-article:17483529 | lifeskim:mentions | umls-concept:C1705604 | lld:lifeskim |
pubmed-article:17483529 | lifeskim:mentions | umls-concept:C0180307 | lld:lifeskim |
pubmed-article:17483529 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:17483529 | pubmed:dateCreated | 2007-7-19 | lld:pubmed |
pubmed-article:17483529 | pubmed:abstractText | Aim In a prospective study, we tested the feasibility of implantable cardioverter-defibrillator (ICD) implantation under local anaesthesia (LA) with minimal sedation (MS) vs. short general anaesthesia (SGA) for defibrillation test (DT). METHODS AND RESULTS: We implanted ICDs in 118 patients between October 2002 and November 2003. Surgery was performed under LA with MS. Depending on the day of admission, patients had DT without SGA with a shock delivered when patient is unconscious (MS group, n = 73) or with short general anaesthesia (SGA group, n = 45). The patients were asked to rate the intensity of pain on a 10-point visual analogue scale (VAS) at the end of the implantation procedure and for the patient of MS group just after DT (VAS-DT). Visual analogue scale was not influenced by the type of anaesthesia (MS vs. SGA). Univariate analysis showed that NYHA >III, 3 leads implanted and an incomplete understanding of the explanation on the procedure were risk factors of VAS >4. Only understanding of the explanation on the procedure has an influence on pain in multivariate analysis. CONCLUSION: ICD implantation under MS even for DT is feasible and acceptable for the patient. | lld:pubmed |
pubmed-article:17483529 | pubmed:language | eng | lld:pubmed |
pubmed-article:17483529 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17483529 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17483529 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17483529 | pubmed:month | Jul | lld:pubmed |
pubmed-article:17483529 | pubmed:issn | 1099-5129 | lld:pubmed |
pubmed-article:17483529 | pubmed:author | pubmed-author:AnemaJ RJR | lld:pubmed |
pubmed-article:17483529 | pubmed:author | pubmed-author:LamblinNicola... | lld:pubmed |
pubmed-article:17483529 | pubmed:author | pubmed-author:LacroixDomini... | lld:pubmed |
pubmed-article:17483529 | pubmed:author | pubmed-author:KlugDidierD | lld:pubmed |
pubmed-article:17483529 | pubmed:author | pubmed-author:MarquiéChrist... | lld:pubmed |
pubmed-article:17483529 | pubmed:author | pubmed-author:KacetSalemS | lld:pubmed |
pubmed-article:17483529 | pubmed:author | pubmed-author:CordovaHélène... | lld:pubmed |
pubmed-article:17483529 | pubmed:author | pubmed-author:BouloMarieM | lld:pubmed |
pubmed-article:17483529 | pubmed:author | pubmed-author:DucheminAudre... | lld:pubmed |
pubmed-article:17483529 | pubmed:author | pubmed-author:MizonFrédériq... | lld:pubmed |
pubmed-article:17483529 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17483529 | pubmed:volume | 9 | lld:pubmed |
pubmed-article:17483529 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17483529 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17483529 | pubmed:pagination | 545-50 | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:meshHeading | pubmed-meshheading:17483529... | lld:pubmed |
pubmed-article:17483529 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17483529 | pubmed:articleTitle | Can we implant cardioverter defibrillator under minimal sedation? | lld:pubmed |
pubmed-article:17483529 | pubmed:affiliation | Department of Cardiology A, Hôpital Cardiologique de Lille, CHRU, Blvd du Pr Leclercq, F-59037 Lille (Cedex), France. c-marquie@chru-lille.fr | lld:pubmed |
pubmed-article:17483529 | pubmed:publicationType | Journal Article | lld:pubmed |